Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03.
Published June 24, 2026 · Recall initiated: May 27, 2026
Summary
FDA records drug Class II recall D-0594-2026, published June 24, 2026 and initiated May 27, 2026. Recalling firm: Ajanta Pharma USA Inc; Status: Ongoing; Reported quantity: 6,143 bottles; Lot: Lot: PA00805, expires: 01/31/2029. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
What to do
Voluntary: Firm initiated · Letter
Get an email if ARIPIPRAZOLE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ARIPIPRAZOLE
- Manufacturer
- Ajanta Pharma USA Inc
- Distributor
- U.S. Nationwide
- UPC
- 0327241051036
- Lot
- Lot: PA00805, expires: 01/31/2029
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compounding Services, LLC. 3650June 24, 2026
- FDABuprenorphine HCl, CIII, Injection, 0.3 mg/mL, 5 x 1 mL Single Dose Vials per Carton, Rx Only, ForJune 24, 2026
- FDAAripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx only, Manufactured by: Alken Laboratories Ltd., INDIA;September 24, 2025
- FDAAripiprazole Tablets, USP, 5 mg, 30 Tablets per bottle, Distributed by: Amneal Pharmaceuticals LLC,January 3, 2024
- FDAAripiprazole Tablets, USP, 20 mg, Rx Only, Packaged in 500-count bottle Manufactured by: Alkem LaboratoriesApril 26, 2023
- FDAAripiprazole Tablets, USP 15 mg Rx Only, Packaged as: a) 30-count bottle NDC 16729-281-10, UPC 3 16729 28110March 8, 2023
Questions about this recall
Was Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03. recalled?
Yes. FDA published recall D-0594-2026 on June 24, 2026. Reported hazard: Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ARIPIPRAZOLE. UPC: 0327241051036.